Unique Ingredient Identifier Z0H242BBR1 is listed as a ingredient substance
| RN | 22839-47-0 |
| EC | 245-261-3 |
| NCIT | C76513 |
| RXCUI | 1311524 |
| INN ID | 3019 |
| MF | C14H18N2O5 |
| INCHI KEY | IAOZJIPTCAWIRG-QWRGUYRKSA-N |
| SMILES | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(O)=O |
UNII Z0H242BBR1 ASPARTAME is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| BUCCAL | PATCH, CONTROLLED RELEASE | 1.1 MG |
| ORAL | CAPSULE | 0.8 MG |
| ORAL | GRANULE, EFFERVESCENT | NA |
| ORAL | GRANULE, FOR SUSPENSION | 35 MG |
| ORAL | POWDER | 450 MG/1PKT |
| ORAL | POWDER, FOR ORAL SOLUTION | 233 MG |
| ORAL | POWDER, FOR ORAL SOLUTION | 0.875 G/16 OZ |
| ORAL | POWDER, FOR ORAL SUSPENSION | 50 MG/PKT |
| ORAL | POWDER, FOR RECONSTITUTION | 12.5 MG/5ML |
| ORAL | POWDER, FOR SOLUTION | 47 MG/100ML |
| ORAL | POWDER, FOR SUSPENSION | 20 MG/1SCP |
| ORAL | SOLUTION | 40 MG |
| ORAL | SUSPENSION | 50 MG/5ML |
| ORAL | SYRUP | 0.63 MG/5ML |
| ORAL | TABLET | 20 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 5.1 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 65 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESC | 30 MG |
| ORAL | TABLET, CHEWABLE | 12 MG |
| ORAL | TABLET, DISPERSIBLE | 2.5 MG |
| ORAL | TABLET, FILM COATED | 20 MG |
| ORAL | TABLET, FOR SUSPENSION | 3.7 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 40 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 13 MG |
| ORAL | TROCHE | 6.1 MG |
| SUBLINGUAL | TABLET | 8 MG |
| TRANSDERMAL | PATCH, ELECTRICALLY CONTROLLED | 9.5 MG |